The stock's fall snapped a three-day winning streak.

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests Bio-Rad leads ...

Shares of Labcorp Holdings Inc. LH inched 0.34% higher to $229.92 Monday, on what proved to be an all-around mixed trading ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line ...

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent ...

In the preceding three months, 8 analysts have released ratings for Labcorp Holdings LH +2.25% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The following table ...

The Federal Circuit on Monday, January 6, rejected Labcorp's argument that the Patent Trial and Appeal Board erred in its ...

The new funding will support the commercial launch of the company's at-home screening test for colorectal cancer, as well as ...

LabCorp and University Health System settle on $388,667 for alleged False Claims Act violations related to Medicare billing.

Labcorp Holdings Inc. LH, or Labcorp, is targeting high-growth areas as part of its expansion. By partnering with health systems and regional local laboratories, the company is leveraging science and ...